AIMS: Radial scars (RS) are benign entities, frequently identified on screening mammography, which may be associated with malignancy. Much debate has been generated with regard to the optimum management of RS. We present our experience of RS in the first 5 years of a screening programme. The aim was to evaluate (i) the incidence of atypia and malignancy and (ii) the value of the preoperative core biopsy. We also further characterize the histological features. METHODS AND RESULTS: One hundred and twenty-five histologically confirmed cases of RS were reviewed (111 had preoperative biopsies). Thirty-one (24.8%) patients had a final malignant diagnosis (11 with invasive malignancy) and 28 (22.4%) showed atypia (including lobular carcinoma in situ). In those with core biopsies and a final malignant diagnosis, 12 cases were categorized as B5 (41.3%), three as B4 (10.3%), 12 as B3 (41.3%) and two as B2 (7%). Common histological features included obliterated ducts and chronic inflammation with, less frequently, neural hyperplasia (16.8%) and perineural invasion (3.2%). CONCLUSIONS: The high incidence of atypia and malignancy identified in our study justifies our policy of removing all mammographically detected RS. We emphasize the utility of preoperative core biopsy evaluation in permitting one-stage surgical therapy in those with B5 diagnoses.
AIMS: Radial scars (RS) are benign entities, frequently identified on screening mammography, which may be associated with malignancy. Much debate has been generated with regard to the optimum management of RS. We present our experience of RS in the first 5 years of a screening programme. The aim was to evaluate (i) the incidence of atypia and malignancy and (ii) the value of the preoperative core biopsy. We also further characterize the histological features. METHODS AND RESULTS: One hundred and twenty-five histologically confirmed cases of RS were reviewed (111 had preoperative biopsies). Thirty-one (24.8%) patients had a final malignant diagnosis (11 with invasive malignancy) and 28 (22.4%) showed atypia (including lobular carcinoma in situ). In those with core biopsies and a final malignant diagnosis, 12 cases were categorized as B5 (41.3%), three as B4 (10.3%), 12 as B3 (41.3%) and two as B2 (7%). Common histological features included obliterated ducts and chronic inflammation with, less frequently, neural hyperplasia (16.8%) and perineural invasion (3.2%). CONCLUSIONS: The high incidence of atypia and malignancy identified in our study justifies our policy of removing all mammographically detected RS. We emphasize the utility of preoperative core biopsy evaluation in permitting one-stage surgical therapy in those with B5 diagnoses.
Authors: Niamh Conlon; Clare D'Arcy; Jennifer B Kaplan; Zenica L Bowser; Anibal Cordero; Edi Brogi; Adriana D Corben Journal: Am J Surg Pathol Date: 2015-06 Impact factor: 6.394
Authors: Gael M Maclean; Stephen P Courtney; Hilary Umeh; Siriathan Sanjeev; Colin McCormick; Brendan M Smith Journal: World J Surg Date: 2013-11 Impact factor: 3.352
Authors: Ying Chen; Tor A Klingen; Elisabeth Wik; Hans Aas; Einar Vigeland; Knut Liestøl; Øystein Garred; Jan Mæhlen; Lars A Akslen; Jon Lømo Journal: Diagn Pathol Date: 2014-12-19 Impact factor: 2.644
Authors: Elizabeth Min Hui Kim; Andrea Hankins; Jamie Cassity; Dennis McDonald; Barbara White; Ron Rowberry; Sharon Dutton; Claire Snyder Journal: Springerplus Date: 2016-03-31